Numerous studies indicate that IHC, under the appropriate conditions, is sensitive and specific for determination of ALK protein expression.[10] Nowadays, Food and Drug Administration and China Food And Drug Administration both approved the Ventana (D5F3) to the screen for ALK rearrangements in the evaluation of NSCLC. Here, ALK is linked to non-small cell lung carcinoma.